Question Title

* 2. If the contact was related to a specific claim of salmonella in your product line, did the FDA/CDC present you with evidence that your products are contaminated with salmonella?

Question Title

* 3. If yes to #2,  did the FDA/CDC link the claim of salmonella contamination to a specific strain or salmonella?

Question Title

* 4. If yes to #2, did the FDA/CDC describe any difference in the alleged salmonella contamination in your product line to any other salmonella strain that has been publicly linked to kratom?

Question Title

* 5. If yes to #2, did the FDA/CDC provide specific written documentation of the laboratory analysis of the alleged salmonella contamination in your product line?

Question Title

* 6. If yes to #2, did you request time to allow for your firm to conduct an independent test to validate the FDA/CDC of salmonella contamination in your product line?

Question Title

* 7. If you did conduct an independent test for salmonella, did it confirm the FDA/CDC analysis on the presence of salmonella, including a match of the alleged salmonella strain?

Question Title

* 9. If so, how much time were you provided to consider a “voluntary recall” and were there any ultimatums issued if you decided to not conduct a “voluntary recall?”

Question Title

* 12. Did the FDA/CDC agents reference any concerns about kratom generally, apart from the salmonella issue? 

Question Title

* 13. If the contact is with a CDC agent alone, was there any reference to the FDA advisories about the purported danger of kratom use in general?

Question Title

* 15. If yes to #14, did your routine testing identify any contamination of salmonella prior to the contact with the FDA/CDC?

Question Title

* 17. Contact Information

T